EcoDrugPlus

Aurora Kinase C

Ensembl ID : ENSBTAG00000003261
Gene Symbol: AURKC
4 Cross references
103 Possible Orthologues:

Aurora Kinase C-Like

Ensembl ID : ENSBTAG00000048283
Gene Symbol: LOC101903509
4 Cross references
102 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSBTAG00000019365
Gene Symbol: BACE1
5 Cross references
233 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSBTAG00000021717
Gene Symbol: BDKRB2
8 Enzyme and pathways 5 Cross references
159 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSBTAG00000011139
Gene Symbol: BCHE
5 Enzyme and pathways 5 Cross references
142 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSBTAG00000008483
Gene Symbol: CALCRL
7 Enzyme and pathways 5 Cross references
160 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSBTAG00000003865
Gene Symbol: CASR
7 Enzyme and pathways 5 Cross references
215 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSBTAG00000020569
Gene Symbol: CACNA2D1
5 Cross references
302 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSBTAG00000009489
Gene Symbol: CACNA2D2
10 Enzyme and pathways 5 Cross references
282 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSBTAG00000013117
Gene Symbol: CACNA2D3
3 Enzyme and pathways 5 Cross references
225 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 4

Ensembl ID : ENSBTAG00000021994
Gene Symbol: CACNA2D4
5 Cross references
326 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 1

Ensembl ID : ENSBTAG00000002036
Gene Symbol: CACNB1
7 Enzyme and pathways 5 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).